Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IGC Pharma (IGC) Operating Margin (2016 - 2025)

IGC Pharma (IGC) has disclosed Operating Margin for 16 consecutive years, with 1517.8% as the latest value for Q3 2025.

  • Quarterly Operating Margin fell 109062.0% to 1517.8% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 731.83% through Sep 2025, down 54112.0% year-over-year, with the annual reading at 585.84% for FY2025, 38286.0% down from the prior year.
  • Operating Margin for Q3 2025 was 1517.8% at IGC Pharma, down from 580.79% in the prior quarter.
  • The five-year high for Operating Margin was 4732.79% in Q1 2022, with the low at 7764.29% in Q3 2021.
  • Average Operating Margin over 5 years is 1173.41%, with a median of 880.88% recorded in 2024.
  • The sharpest move saw Operating Margin skyrocketed 817847bps in 2022, then tumbled -716592bps in 2023.
  • Over 5 years, Operating Margin stood at 1679.58% in 2021, then skyrocketed by 59bps to 686.14% in 2022, then crashed by -114bps to 1469.61% in 2023, then surged by 50bps to 730.74% in 2024, then plummeted by -108bps to 1517.8% in 2025.
  • According to Business Quant data, Operating Margin over the past three periods came in at 1517.8%, 580.79%, and 427.88% for Q3 2025, Q2 2025, and Q1 2025 respectively.